Eye Plastic Surgery Associates

What Eye Plastic Surgery Associates does

Eye Plastic Surgery Associates is a solo oculoplastic surgery medical practice headquartered at 7777 Forest Lane in Dallas, Texas, operating under the DBAs "Eye Plastic Surgery Associates" and "EyePlastics." The practice is owned and operated by Dr. Mark L. Mazow, MD, F.A.C.S., a board-certified ophthalmologist and fellowship-trained oculoplastic surgeon who is an ASOPRS Fellow (fewer than 600 active members worldwide) and holds an Ocular Oncology and Pathology fellowship from Barnes-Jewish Hospital/Washington University Medical School. Dr. Mazow has served as Clinical Professor of Ophthalmology at the University of Texas Southwestern Medical School since 1990.

The practice delivers a comprehensive range of surgical and non-surgical services across four service lines: eyelid procedures (blepharoplasty, ptosis repair, brow lift, blepharospasm, skin tumors, congenital conditions), lacrimal system procedures (DCR for blocked tear ducts), orbital procedures (thyroid eye disease, anophthalmos/socket reconstruction, orbital tumors, trauma), and cosmetic procedures (botulinum toxin, dermal fillers, CO2 laser resurfacing, fractional laser, RF microneedling, facelift, facial fat grafting, Latisse). Patient acquisition is primarily referral-driven from optometrists, ophthalmologists, and primary care physicians across the Dallas-Fort Worth metroplex, with no online booking or telemedicine.

Revenue is generated through professional services billing, combining insurance-reimbursed functional procedures (medically necessary blepharoplasty, ptosis repair, DCR, thyroid eye disease treatment) with self-pay cosmetic procedures. The practice accepts Medicare, Medicaid, Aetna, Blue Cross Blue Shield of Texas, UnitedHealthCare, Cigna, Humana, Tricare, and other major plans. A partnership with Medical City Children's Hospital supports pediatric oculoplastic cases through collaboration with Pediatric Oncology and Pediatric Endocrinology. Pricing is not publicly disclosed, and no headcount, revenue, or patient volume figures are reported.

Name

Eye Plastic Surgery Associates

Legal name

Eye Plastic Surgery Associates

Website

https://drmarkmazow.com

Company type

Private

Operating status

Operating

Short description

Eye Plastic Surgery Associates is a solo oculoplastic surgery practice in Dallas, Texas, led by Dr. Mark Mazow, offering cosmetic and reconstructive surgical and non-surgical procedures for the eyelids, orbit, and lacrimal system to patients across the Dallas-Fort Worth metroplex.

Ownership category

akta.pro rank

Product category

Oculoplastic Surgery

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oculoplastics & Orbital Surgery (HLAKAKAI)

akta.pro secondary industry

Facial Plastic & Reconstructive Surgery (ENT) (HLAKAMAG)

Keywords

• Oculoplastic surgery
• Eyelid surgery
• Cosmetic eye surgery
• Orbital surgery
• Lacrimal surgery

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Surgical Professional Services: Revenue from surgical procedures including blepharoplasty, brow lift, ptosis repair, orbital surgery, and lacrimal procedures. Combines insurance-billed functional procedures with self-pay cosmetic procedures.
2. Insurance-Reimbursed Procedures: Functional blepharoplasty (when excess upper eyelid skin obstructs vision) and ptosis repair are often covered by insurance when visual field testing demonstrates significant visual field defect. Lacrimal procedures (DCR) and thyroid eye disease treatments may also be covered.
3. Self-Pay Cosmetic Procedures: Cosmetic procedures including cosmetic blepharoplasty, facelift, fillers, botulinum toxin, laser resurfacing are self-pay. Prices not publicly disclosed.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Eye Plastic Surgery Associates is a solo oculoplastic surgery practice offering surgical and non-surgical procedures for conditions of the eyelids, orbit, and lacrimal (tear duct) system. Services span cosmetic eyelid and facial rejuvenation (blepharoplasty, brow lift, fillers, botulinum toxin, laser resurfacing), functional eyelid correction (ptosis repair, eyelid malposition), thyroid eye disease treatment, orbital tumor management, and blocked tear duct surgery. The practice delivers care through direct office consultation from a single Dallas location.

Product overview

Eye Plastic Surgery Associates is a single-location oculoplastic surgery practice led by Dr. Mark Mazow offering a comprehensive range of surgical and non-surgical services for conditions of the eyelids, orbit, and lacrimal (tear duct) system. The practice operates across four main service categories: Eyelid Procedures (including blepharoplasty, ptosis repair, blepharospasm, brow lift, skin tumors, and symblepharon), Lacrimal System Procedures (treatment of blocked tear ducts and DCR surgery), Orbital Procedures (thyroid eye disease, orbital tumors, trauma, and anophthalmos), and Cosmetic Procedures (botulinum toxin, fillers, laser resurfacing, facelifts, and skin rejuvenation). The practice also provides patient education resources including anatomy guides and downloadable brochures. Services are delivered at a single Dallas location (7777 Forest Lane) with no digital product, API, or technology platform components.

Differentiator

Problem solved

Functional benefit

Products and services

• Blepharoplasty Upper and lower eyelid blepharoplasty ("eye lift") — cosmetic and functional correction of excess eyelid skin and fat for adult patients with dermatochalasis or visual field obstruction.
• Asian Blepharoplasty Double eyelid surgery creating or enhancing a supratarsal crease in Asian eyelids using non-incisional suture or incisional techniques.
• Ptosis Repair Repair of drooping upper eyelids (ptosis) — both cosmetic and functional correction of levator muscle weakness.
• Endoscopic Brow Lift Minimally invasive brow lift using five small scalp incisions and an endoscope to release and re-suspend descended brows with faster recovery than traditional coronal lift.
• Blepharospasm Treatment Diagnosis and treatment of essential blepharospasm and hemifacial spasm — including botulinum toxin injection and surgical myectomy.
• Thyroid Eye Disease Treatment Comprehensive treatment of Thyroid Eye Disease including orbital decompression, eyelid retraction surgery, strabismus correction, and coordination for Tepezza (teprotumumab) infusion therapy.
• Orbital Decompression Surgery Surgical enlargement of the bony orbit to relieve proptosis and optic-nerve compression in thyroid eye disease.
• Dacryocystorhinostomy (DCR) Surgical bypass of blocked nasolacrimal duct creating a new drainage pathway between the lacrimal sac and nasal cavity, performed externally or endoscopically.
• Botulinum Toxin Treatment Botulinum toxin neuromodulators (Botox, Dysport, Xeomin, Jeuveau, Daxxify) for cosmetic treatment of dynamic wrinkles and therapeutic treatment of blepharospasm and hemifacial spasm.
• Dermal Fillers Hyaluronic acid and biostimulatory dermal fillers for periorbital and facial volume restoration including tear trough, cheeks, lips, and nasolabial folds.
• CO2 Laser Resurfacing CO2 laser resurfacing for periocular skin tightening, smoothing crow's feet, treating festoons, and improving skin quality around the eyes.
• RF Microneedling Radiofrequency microneedling combining micro-injuries with RF energy to stimulate collagen and tighten periocular skin with minimal downtime.
• Anophthalmos & Socket Reconstruction Surgical and prosthetic management of anophthalmos (absence of the eye) including evisceration, enucleation, exenteration, orbital implants, dermis-fat graft, and custom ocular prosthesis fitting.
• Capillary Hemangioma Treatment Treatment of infantile capillary hemangioma including observation, oral propranolol, topical timolol, steroid injection, and surgical excision with amblyopia management.
• Eyelid Skin Tumor Removal Diagnosis and surgical removal of benign and malignant eyelid skin tumors with reconstruction — including basal cell, squamous cell, and melanoma, with Mohs reconstruction.
• Orbital Tumor Management Surgical diagnosis and management of adult and pediatric orbital tumors with coordinated care.

Quantifiable outcome

• DCR success rate 90-95%
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Medical City Children's HospitalcoreStrategic or Co-development PartnerCollaborates with Pediatric Oncology and Pediatric Endocrinology teams at Medical City Children's Hospital in Dallas for pediatric patients with oculoplastic conditions including congenital eyelid disorders, orbital tumors, and thyroid eye disease in children.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Sono Bello: National cosmetic surgery chain specializing in body contouring and facial procedures with physician-led delivery. Comparable as a broad incumbent in branded cosmetic surgery competing for self-pay aesthetic patients across multiple US metros.
• Bosley: Largest US hair restoration brand with multi-location clinics performing cosmetic surgical procedures. Comparable as a broad incumbent in branded cosmetic surgery with self-pay aesthetic procedure volume and a national marketing footprint.
• Ideal Image: Largest US aesthetics chain offering botulinum toxin, fillers, laser hair removal, and body contouring across 150+ locations. Comparable as a broad incumbent competing for the same self-pay cosmetic patient wallet, although without oculoplastic specialization.

Emerging players

• SkinSpirit: Aesthetic medical practice chain offering injectables, lasers, and skin rejuvenation with a medical-spa-plus-provider model. Comparable as an emerging player encroaching on periocular aesthetic procedures (fillers, botulinum toxin, laser) that overlap with the cosmetic side of the subject practice.
• LaserAway: Largest US aesthetic laser and injectables chain with a strong digital-first marketing approach. Comparable as an emerging player competing for younger self-pay aesthetic patients through digital booking and brand marketing.

Regional players

• TLC Laser Eye Centers: Refractive surgery chain operating LASIK and cataract centers across the US and Canada. Comparable because it operates within the broader ophthalmic surgical services space, though focused on refractive rather than oculoplastic procedures.
• LasikPlus: Multi-location refractive surgery provider offering LASIK and PRK across US metros. Comparable as a regional ophthalmic surgery brand in the same clinical-adjacent category, although focused on refractive rather than periocular plastic surgery.

Direct peers

• Pamel Vision & Laser Group: Oculoplastic and ophthalmology practice specializing in eyelid surgery, cosmetic eye procedures, and reconstructive work. Comparable because it offers a similar scope of cosmetic and functional eyelid procedures to a regional patient base.
• Eyesthetica: A multi-surgeon oculoplastic and cosmetic surgery practice in Los Angeles offering eyelid, orbital, and facial cosmetic procedures. Comparable because it operates in the same oculoplastic surgery niche with fellowship-trained surgeons serving a metro referral base.

Others

• American Society of Ophthalmic Plastic and Reconstructive Surgeons (ASOPRS) Member Directory Practices: The ASOPRS member directory lists fewer than 600 fellowship-trained oculoplastic surgeons across the US, most operating solo or small-group practices. Listed as an ecosystem reference because direct head-to-head competition for fellowship-trained oculoplastic referrals comes primarily from this directory's members in DFW and adjacent metros.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/drmarkmazow
• Facebookfacebook.com/texaseyeliddoc
• LinkedInlinkedin.com/company/eye-plastic-surgery-associates-pa

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eye Plastic Surgery Associates